Based in San Diego, Locana Bio is built on the concept that gene therapy can deliver RNA-directed proteins to prevent or treat disease by targeting and modifying dysfunctional RNA . . .
Home Genome Editing Gene Therapy Shooting the Messenger: Locana Bio Writes a New Script for RNA Diseases
Shooting the Messenger: Locana Bio Writes a New Script for RNA Diseases
The San Diego start-up is creating a new class of gene therapies by targeting dysfunctional RNA
Source: David Bushnell, Ken Westover and Roger Kornberg, Stanford University
![Spark Therapeutics saw its share price tumble about 30% in early-morning trading after it reported mixed preliminary data this morning from a Phase I/II trial of its hemophilia A gene therapy candidate SPK-8001. [Source: wildpixel/Getty Images]](https://sandbox.genengnews.com/wp-content/uploads/2018/08/Dec7_2017_Getty_487489316_GeneTherapy_60019871441892139879144-100x70.jpg "Novel Gene Therapy for Duchenne Muscular Dystrophy Shows Promise")